Literature DB >> 12218810

H(2) (15)0 positron emission tomography validation of semiquantitative prostate blood flow determined by double-echo dynamic MRI: a preliminary study.

Satoshi Muramoto1, Hidemasa Uematsu, Norihiro Sadato, Tatsuro Tsuchida, Tsuyoshi Matsuda, Hiroto Hatabu, Yoshiharu Yonekura, Harumi Itoh.   

Abstract

PURPOSE: Information regarding prostate blood flow as determined by positron emission tomography (PET) with H 0 may provide useful information about tumor diagnosis; however, PET requires a cyclotron for the production of an extremely short half-life (2 minutes) tracer. Therefore, the aim of this study was to propose a complementary index for blood flow as determined by MRI to validate the results and compare them with PET, especially for prostate tissue.
METHODS: Six consecutive patients with prostate disease were studied. The two semiquantitative indices for tumor blood flow were calculated from the time-concentration curve measured from double-echo MR images. The theory of nondiffusible tracers by means of indicator dilution theory was applied to MR data. The relative regional blood flow (rrBF) was calculated as the ratio of the relative regional blood volume to relative regional mean transit time. Another proposed index was the maximum height of the time-concentration curve. PET studies were also performed, and absolute blood flow values were calculated for each subject. These indices calculated from different modalities were then compared.
RESULTS: A significant correlation was found between the rrBF and the absolute blood flow as determined by PET (r = 0.69, p < 0.005). A significant correlation was also found between the maximum height of the time-concentration curve and the absolute blood flow (r = 0.85, p < 0.0001).
CONCLUSIONS: The semiquantitative tumor blood flow indices measured with MRI have a good correlation with the corresponding measurements by PET; therefore, these indices may provide useful information about tumor diagnosis in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218810     DOI: 10.1097/00004728-200207000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Non-invasive quantification of tumor blood flow in prostate cancer using 15O-H2O PET/CT.

Authors:  Lars P Tolbod; Maria M Nielsen; Bodil G Pedersen; Søren Høyer; Hendrik J Harms; Michael Borre; Per Borghammer; Kirsten Bouchelouche; Jørgen Frøkiær; Jens Sørensen
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-10-20

2.  Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters.

Authors:  C Chad Quarles; John C Gore; Lei Xu; Thomas E Yankeelov
Journal:  Magn Reson Imaging       Date:  2012-05-21       Impact factor: 2.546

Review 3.  Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability.

Authors:  Hidemasa Uematsu; Masayuki Maeda
Journal:  Eur Radiol       Date:  2005-06-14       Impact factor: 5.315

4.  Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.

Authors:  Peter R Eby; Savannah C Partridge; Steven W White; Robert K Doot; Lisa K Dunnwald; Erin K Schubert; Brenda F Kurland; Constance D Lehman; David A Mankoff
Journal:  Acad Radiol       Date:  2008-10       Impact factor: 3.173

5.  Reproducibility of tumor blood flow quantification with 15O-water PET.

Authors:  Martin A Lodge; Heather A Jacene; Roberto Pili; Richard L Wahl
Journal:  J Nucl Med       Date:  2008-10       Impact factor: 10.057

6.  Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [11C]-Acetate PET/CT.

Authors:  Naresh Regula; Hadis Honarvar; Mark Lubberink; Håkan Jorulf; Sam Ladjevardi; Michael Häggman; Gunnar Antoni; Jos Buijs; Irina Velikyan; Jens Sörensen
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.